One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.

According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

Astronomy interviews Sally Ride's life partner Tam O’Shaughnessy and director Cristina Costantini ahead of 'Sally' documentary release June 16.

Explore daily insights on the USA TODAY crossword puzzle by Sally Hoelscher. Uncover expert takes and answers in our crossword blog.

After solidifying your menu options, Susman recommends incorporating special touches to your bash. "For the 4th of July, I love blending casual comfort with elevated details. … ...

Pfizer CEO talks Chinese due diligence, ADC synergies to justify $6B bet on 'fabulous' bispecific By Nick Paul Taylor Jun 10, 2025 9:56am Pfizer checkpoint inhibitors PD-1/L1 immuno-oncology ...

Pfizer is expected to post earnings of $0.57 per share for the current quarter, representing a year-over-year change of -5%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.7%.

Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s move for a lot less money.